QT-prolonging drugs: Should they ever be used?
| dc.contributor.author | Okreglicki, Andrzej | |
| dc.date.accessioned | 2017-04-12T07:32:24Z | |
| dc.date.available | 2017-04-12T07:32:24Z | |
| dc.date.issued | 2005 | |
| dc.date.updated | 2016-01-05T07:42:07Z | |
| dc.description.abstract | If the current stringent conditions of bodies that register and control medicines had been in force for decades, many commonly used drugs (from antibiotics and antihistamines to antipsychotics and antiarrhythmics) would never have reached the consumer market. Nowadays, pre-release findings of QT prolongation are likely to scupper early-phase trials and result in the abandonment of experimental drugs. Post-marketing surveillance has identified a number of commonly used drugs either as causing QT prolongation or associated with increased sudden unexpected deaths.1 Thioridazine (see p. 46 of this issue) is such a drug. | |
| dc.identifier.apacitation | Okreglicki, A. (2005). QT-prolonging drugs: Should they ever be used?. <i>South African Journal of Psychiatry</i>, http://hdl.handle.net/11427/24189 | en_ZA |
| dc.identifier.chicagocitation | Okreglicki, Andrzej "QT-prolonging drugs: Should they ever be used?." <i>South African Journal of Psychiatry</i> (2005) http://hdl.handle.net/11427/24189 | en_ZA |
| dc.identifier.citation | Okreglicki, A. (2005). QT-prolonging drugs: should they ever be used?: editorial. South African Journal of Psychiatry, 11(2), p-40. | |
| dc.identifier.ris | TY - Journal Article AU - Okreglicki, Andrzej AB - If the current stringent conditions of bodies that register and control medicines had been in force for decades, many commonly used drugs (from antibiotics and antihistamines to antipsychotics and antiarrhythmics) would never have reached the consumer market. Nowadays, pre-release findings of QT prolongation are likely to scupper early-phase trials and result in the abandonment of experimental drugs. Post-marketing surveillance has identified a number of commonly used drugs either as causing QT prolongation or associated with increased sudden unexpected deaths.1 Thioridazine (see p. 46 of this issue) is such a drug. DA - 2005 DB - OpenUCT DP - University of Cape Town J1 - South African Journal of Psychiatry LK - https://open.uct.ac.za PB - University of Cape Town PY - 2005 T1 - QT-prolonging drugs: Should they ever be used? TI - QT-prolonging drugs: Should they ever be used? UR - http://hdl.handle.net/11427/24189 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/24189 | |
| dc.identifier.vancouvercitation | Okreglicki A. QT-prolonging drugs: Should they ever be used?. South African Journal of Psychiatry. 2005; http://hdl.handle.net/11427/24189. | en_ZA |
| dc.language.iso | eng | |
| dc.publisher.department | Division of Cardiology | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | South African Journal of Psychiatry | |
| dc.source.uri | http://www.sajp.org.za/index.php/sajp | |
| dc.title | QT-prolonging drugs: Should they ever be used? | |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |